Net Income Summary of PharmaEngine, Inc.

PharmaEngine, Inc.'s latest annual net income in 2023 was 274.65 Million TWD , down -13.84% from previous year.
PharmaEngine, Inc.'s latest quarterly net income in 2024 Q2 was 158.86 Million TWD , up 94.39% from previous quarter.
PharmaEngine, Inc. reported an annual net income of 318.78 Million TWD in 2022, down -25.17% from previous year.
PharmaEngine, Inc. reported an annual net income of 426.03 Million TWD in 2021, down -29.5% from previous year.
PharmaEngine, Inc. reported a quarterly net income of 81.72 Million TWD for 2024 Q1, up 118.68% from previous quarter.
PharmaEngine, Inc. reported a quarterly net income of 80.78 Million TWD for 2023 Q3, up 7.54% from previous quarter.

Annual Net Income Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Net Income of PharmaEngine, Inc. (2023 - 2009)

Year	Net Income	Net Income Growth
2023	274.65 Million TWD	-13.84%
2022	318.78 Million TWD	-25.17%
2021	426.03 Million TWD	-29.5%
2020	604.28 Million TWD	1320.17%
2019	42.55 Million TWD	-67.11%
2018	129.36 Million TWD	-66.58%
2017	387.06 Million TWD	-43.87%
2016	689.62 Million TWD	75.02%
2015	394.02 Million TWD	218.81%
2014	123.59 Million TWD	204.87%
2013	-117.84 Million TWD	-340.57%
2012	48.98 Million TWD	-82.85%
2011	285.7 Million TWD	693.36%
2010	-48.15 Million TWD	51.22%
2009	-98.7 Million TWD	0.0%

Year	Net Income	Net Income Growth
2024 Q2	158.86 Million TWD	94.39%
2024 Q1	81.72 Million TWD	118.68%
2023 Q3	80.78 Million TWD	7.54%
2023 Q4	37.37 Million TWD	-53.74%
2023 FY	274.65 Million TWD	-13.84%
2023 Q1	81.38 Million TWD	51.78%
2023 Q2	75.11 Million TWD	-7.7%
2022 Q1	97.03 Million TWD	-13.0%
2022 Q2	80.67 Million TWD	-16.86%
2022 Q3	87.46 Million TWD	8.42%
2022 Q4	53.61 Million TWD	-38.7%
2022 FY	318.78 Million TWD	-25.17%
2021 Q1	75.68 Million TWD	-85.52%
2021 Q2	165.66 Million TWD	118.88%
2021 Q3	73.15 Million TWD	-55.84%
2021 Q4	111.53 Million TWD	52.46%
2021 FY	426.03 Million TWD	-29.5%
2020 Q3	18.38 Million TWD	27.87%
2020 Q2	14.37 Million TWD	-70.55%
2020 FY	604.28 Million TWD	1320.17%
2020 Q1	48.82 Million TWD	232.11%
2020 Q4	522.68 Million TWD	2742.86%
2019 Q3	23.67 Million TWD	-17.35%
2019 FY	42.55 Million TWD	-67.11%
2019 Q4	-36.95 Million TWD	-256.12%
2019 Q2	28.64 Million TWD	5.32%
2019 Q1	27.19 Million TWD	-20.32%
2018 Q2	70.15 Million TWD	242.74%
2018 Q3	74.22 Million TWD	5.81%
2018 FY	129.36 Million TWD	-66.58%
2018 Q4	34.13 Million TWD	-54.02%
2018 Q1	-49.14 Million TWD	-108.91%
2017 Q1	-125.51 Million TWD	-120.36%
2017 Q3	-3.56 Million TWD	89.97%
2017 Q2	-35.49 Million TWD	71.72%
2017 Q4	551.63 Million TWD	15590.99%
2017 FY	387.06 Million TWD	-43.87%
2016 FY	689.62 Million TWD	75.02%
2016 Q4	616.43 Million TWD	773.77%
2016 Q3	-91.49 Million TWD	-144.05%
2016 Q2	207.68 Million TWD	583.03%
2016 Q1	-42.99 Million TWD	-35.76%
2015 FY	394.02 Million TWD	218.81%
2015 Q4	-31.66 Million TWD	-191.15%
2015 Q3	34.74 Million TWD	-91.79%
2015 Q2	423.35 Million TWD	1406.37%
2015 Q1	-32.4 Million TWD	-0.05%
2014 Q3	193.43 Million TWD	782.55%
2014 Q2	-28.34 Million TWD	-210.98%
2014 Q1	-9.11 Million TWD	56.22%
2014 FY	123.59 Million TWD	204.87%
2014 Q4	-32.39 Million TWD	-116.75%
2013 Q3	-69.71 Million TWD	-317.33%
2013 Q1	-10.61 Million TWD	17.07%
2013 Q2	-16.7 Million TWD	-57.35%
2013 Q4	-20.81 Million TWD	70.14%
2013 FY	-117.84 Million TWD	-340.57%
2012 Q3	-65.69 Million TWD	-732.57%
2012 Q4	-12.8 Million TWD	80.51%
2012 Q2	-7.89 Million TWD	-105.83%
2012 FY	48.98 Million TWD	-82.85%
2012 Q1	135.32 Million TWD	351.37%
2011 Q2	268.2 Million TWD	1451.51%
2011 FY	285.7 Million TWD	693.36%
2011 Q4	29.98 Million TWD	307.12%
2011 Q1	-19.84 Million TWD	0.0%
2011 Q3	7.36 Million TWD	-97.25%
2010 FY	-48.15 Million TWD	51.22%
2009 FY	-98.7 Million TWD	0.0%

Peer Net Income Comparison of PharmaEngine, Inc.

Name	Net Income	Net Income Difference
Anti-Microbial Savior BioteQ Co., Ltd	-51.78 Million TWD	630.397%
SYN-TECH Chem. & Pharm. Co., Ltd.	251.01 Million TWD	-9.417%
Level Biotechnology Inc.	62.9 Million TWD	-336.611%
Sagittarius Life Science Corp	-55.03 Million TWD	599.01%
NeoCore Technology Co., Ltd.	-64.64 Million TWD	524.859%
TaiMed Biologics Inc.	-194.81 Million TWD	240.984%
GlycoNex Incorporation	-178.36 Million TWD	253.985%
VBI	-6.6 Million TWD	4260.733%
GeneReach Biotechnology Corp.	-166.27 Million TWD	265.183%
Taiwan Advance Bio-Pharmaceutical Inc.	-10.68 Million TWD	2671.148%
SynCore Biotechnology Co.,Ltd	-38.17 Million TWD	819.506%
Genomics BioSci & Tech. Co.,Ltd.	-168.06 Million TWD	263.418%
Visgeneer Inc.	-19.58 Million TWD	1502.062%
Mycenax Biotech Inc.	-682.84 Million TWD	140.221%
Sunmax Biotechnology Co., Ltd.	625.7 Million TWD	56.106%
G&E Herbal Biotechnology Co., Ltd.	72.4 Million TWD	-279.351%
Neith Corporation	-40.03 Million TWD	786.059%
Medigen Vaccine Biologics Corporation	-1.15 Billion TWD	123.68%
TaiwanJ Pharmaceuticals Co., Ltd.	-6.04 Million TWD	4641.922%
Enimmune corporation	-223.74 Million TWD	222.752%
TaiRx, Inc.	-212.29 Million TWD	229.374%
CHO Pharma, Inc.	-306.08 Million TWD	189.729%
EirGenix Inc.	-915.2 Million TWD	130.01%
BioLASCO Taiwan Co., Ltd.	49.74 Million TWD	-452.138%
Sunny Pharmtech Inc.	-63.32 Million TWD	533.749%
Lin BioScience, Inc.	-687.19 Million TWD	139.967%
BioGend Therapeutics Co., Ltd.	-156.32 Million TWD	275.692%
Feng Chi Biotech Corp.	22.79 Million TWD	-1105.028%
Bio Preventive Medicine Corp.	-73.28 Million TWD	474.77%
Lukas Biomedical Inc.	-47.35 Million TWD	680.005%
RBC Bioscience Corporation	6.43 Million TWD	-4171.384%
BiOptic Inc.	37.74 Million TWD	-627.607%
BRIM Biotechnology, Inc.	-688.02 Million TWD	139.919%
Shine-On BioMedical Co.,Ltd.	-37.16 Million TWD	839.002%
Great Novel Therapeutics Biotech & Medicals	-61.54 Million TWD	546.295%
Syngen Biotech Co.,Ltd.	274.82 Million TWD	0.064%
Advagene Biopharma Co., Ltd.	-92.11 Million TWD	398.176%
NaviFUS Corp.	-65.72 Million TWD	517.852%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	-88.08 Million TWD	411.787%
Sinew Pharma Inc.	-170.92 Million TWD	260.688%
Andros Pharmaceuticals Co.,Ltd	-68.15 Million TWD	502.955%
Greenyn Biotechnology Co., Ltd	130.66 Million TWD	-110.196%
Lumosa Therapeutics Co., Ltd.	-238.04 Million TWD	215.379%
AP Biosciences Inc	-339.29 Million TWD	180.947%
Medigen Biotechnology Corp.	-561.29 Million TWD	148.931%
3D Global Biotech Inc.	-57.95 Million TWD	573.935%
Pharmosa Biopharm Inc.	8.45 Million TWD	-3147.99%
Intech Biopharm Corporation	-337.98 Million TWD	181.261%
Oneness Biotech Co., Ltd.	-1.31 Billion TWD	120.92%
Eusol Biotech Co.,Ltd.	-51.61 Million TWD	632.133%
TWi Biotechnology, Inc.	-170.68 Million TWD	260.912%
Ever Supreme Bio Technology Co., Ltd	539.39 Million TWD	49.082%
TCI GENE Inc.	11.67 Million TWD	-2252.866%
MegaPro Biomedical Co., Ltd	-127.54 Million TWD	315.331%
Senhwa Biosciences, Inc.	-296.3 Million TWD	192.691%
Taiwan Bio Therapeutics Co., Ltd	-217.51 Million TWD	226.269%
NatureWise Biotech & Medicals Corporation	10.12 Million TWD	-2613.933%
Savior Lifetec Corporation	30.03 Million TWD	-814.585%
TaiGen Biopharmaceuticals Holdings Limited	136.73 Million TWD	-100.869%
OBI Pharma, Inc.	-1.04 Billion TWD	126.245%
Meribank Biotech Co., Ltd	-125.34 Million TWD	319.113%
Acepodia, Inc.	-817.31 Million TWD	133.604%
Caliway Biopharmaceuticals Co., Ltd.	-488.45 Million TWD	156.228%

Global Stocks Search

PharmaEngine, Inc. (4162.TWO)

Net Income Summary of PharmaEngine, Inc.

Annual Net Income Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Net Income of PharmaEngine, Inc. (2023 - 2009)

Peer Net Income Comparison of PharmaEngine, Inc.